Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologist Recalls Personal Experience with RA

Monica Piecyk, MD  |  Issue: May 2015  |  May 15, 2015

Several months later, my symptoms had improved, but not as much as I had hoped. My next challenge was to get a TNF inhibitor approved. Again, I found myself caught between wanting to be a well-behaved patient and wanting to take control. After my office visit, I politely waited a week before calling the office. When two weeks had passed and I still did not have approval for my medication, I called my insurance company, then two pharmacies and then the doctor’s office again. Finally, the shipment was arranged. All told, it took about a month before I received the medication. I understood my patients’ frustrations to a much better degree. However, I had something that most patients don’t have: rheumatologist colleagues.

When my first dose was delayed, a colleague offered to give me my first TNF inhibitor injection. Initially I declined, because I felt guilty about going outside the system and taking advantage of this perk—one not available to my patients. The following week, as I continued to hobble through the halls of the hospital and still did not have the package at my doorstep, I shamelessly went to his office for my first injection.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Simple Tasks

During the ACR/ARHP Annual Meeting that I attended that first fall, the Simple Tasks campaign had personal meaning for me. On the morning of the first full day of meetings, I attempted to open a small travel jar containing a liquid with which to tame my curly hair on a humid day. My hands would not cooperate. I used a dry washcloth and then a wet washcloth, again without success. Next, I held the jar under warm running water, but again, I could not open it. I filled a glass with hot water and soaked the jar in it, but even with this maneuver I could not open the jar. At this point, my options were either to bring the jar to the front desk and ask for assistance or to live with frizzy hair for the day. I opted for untamed hair. When I returned to my hotel room that evening, I opened the jar without difficulty. As the meeting progressed, the simple task of walking from place to place in the large venue became more difficult for me.

At the most recent Annual Meeting, I felt a sense of privilege. It’s the rare RA patient who gets to peruse and understand the latest posters with her own interests in mind. During sessions on RA, I thought not only about how this information might benefit my patients, but also about how it might benefit me. How can I lower my risk for cardiovascular disease? How I can I optimize my use of methotrexate? The presenters’ frequent use of “we” (i.e., the rheumatologists) and “they” (i.e., the patients) also caught my attention.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I counsel patients all the time & felt this should somehow make me better equipped. I discovered instead that there is an enormous emotional component when the patient is me.

Lessons Learned

My experience during the past three years has taught me many lessons. I have a greater appreciation for my patients’ experiences, especially those with inflammatory arthritis. Although each patient’s symptoms may differ, I now have first-hand experience with joint pain and morning stiffness. My own experience has helped me better understand my patients’ daily limitations and fears, including the fear of not being able to do what they love. It has made me quicker to realize when someone needs better control of their arthritis in order to function. The amazing resilience and ability to cope some patients exhibit are even more apparent to me now.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOpinionPatient PerspectivePractice SupportProfilesRheumatoid ArthritisSpeak Out Rheum Tagged with:DiagnosisManagementPhysician–PatientRheumatoid arthritisrheumatologistSpeak Out Rheumatology

Related Articles

    Chronotherapy with Glucorticoids in Rheumatoid Arthritis

    January 17, 2011

    Time is of the essence in balancing risks and benefits

    Rheumatology with Rhythm

    February 1, 2008

    The circadian rhythm offers insight into treating rheumatic diseases

    Nonsurgical Treatments Can Relieve Pain, Improve Hand Function in Thumb Carpometacarpal Joint Osteoarthritis

    March 1, 2014

    OA can affect hand anatomy and kinematics, but splinting, exercise techniques, and physical agent modalities can help

    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences